Neurocognitive deficits in survivors of childhood acute myeloid leukemia

BACKGROUND: Although treatment of acute myeloid leukemia (AML) contains neurotoxic agents, studies investigating neurocognitive outcomes in children with AML are sparse. We evaluated late cognitive effects in children treated with a high-dose cytarabine based regimen, focusing on general intellectua...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Satoko, Sato, Satomi, Igarashi, Shunji, Dairoku, Hitoshi, Takiguchi, Yuichi, Takimoto, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123816/
https://www.ncbi.nlm.nih.gov/pubmed/35597905
http://dx.doi.org/10.1186/s12887-022-03369-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123816/
https://www.ncbi.nlm.nih.gov/pubmed/35597905
http://dx.doi.org/10.1186/s12887-022-03369-0

Ejemplares similares